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Cruz and colleagues [1] have called appropriately for a
reappraisal of RIFLE and AKIN and have thoughtfully detailed
many of the issues with these progressive consensus
definitions of acute kidney injury (AKI) and with the ways in
which they have been applied. They see the elimination of the
glomerular filtration rate (GFR) criteria from the AKIN
definition as serendipitously discouraging the incorrect use of
changes in estimated GFR for AKI diagnosis. We note that it
also serendipitously removed the errors in degree of GFR
change of the RIFLE R and F criteria definitions compared to
the percentage change in creatinine [2]. Nevertheless, we
would argue that further refinement of AKI definitions should
allow for optional measured changes in GFR to await the
possibility that real-time measures of GFR become available.
After all, creatinine is merely a surrogate marker for GFR and
a poor one at that. Furthermore, the incremental ‘creatinine
creep’ type of AKI (0.1 mg/dl/day) illustrated by the authors
might then be quickly revealed as incremental injury and loss
of GFR.
We concur that integration of novel biomarkers into the
consensus definition is desirable when these biomarkers
identify specific types and severity of injury (as opposed to
change in function) and essential when they have been
demonstrated to predict hard outcomes (such as dialysis or
death). A definition of AKI that incorporated both evidence of
cellular injury and change in function might allow better
clinico-pathological correlation and eliminate staging
uncertainty, for example, that associated with a decreasing
versus an increasing creatinine.
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AKI = acute kidney injury; GFR = glomerular filtration rate.
Authors response
Dinna N Cruz, Zaccaria Ricci and Claudio Ronco
Drs Pickering and Endre called for optional use of changes in
measured GFR in AKI definitions. As they correctly noted, we
would like to discourage the erroneous yet widespread use of
the change in estimated GFR to define AKI. In their commen-
tary, they also note that the removal of the GFR criteria from
RIFLE/AKIN will reduce misclassification arising from the lack
of correspondence between the change in GFR and change
in serum creatinine [2].
An essential feature of a good working definition is that it
should be easy to understand and apply in a variety of clinical
and research settings. We agree that when real-time
measures of GFR become available for routine clinical use
they will contribute to a more precise definition of AKI.
Unfortunately, measuring true GFR is still cumbersome and,
therefore, not part of routine clinical practice today. Although
we concur that an AKI definition incorporating both ‘evidence
of cellular injury and change in renal function’ would be highly
desirable, they are not indispensable for a clinical definition
that is both practical and usable at the bedside, as
experience with sepsis [3] and acute respiratory distress
syndrome/acute lung injury [4] consensus definitions has
shown us. Furthermore, the fact that the original consensus
definition [5] remains one of the most highly accessed
medical articles and is used in over 40 studies [6] confirms
that there is a strong need for such a consensus, albeit with
its limitations.
The AKI consensus definition is dynamic in nature. When, in
the future, conclusive data on novel biomarkers (or
combinations thereof) and routine real-time GFR measures
emerge, these will be used for further improvement of the
definition, and additional studies will be necessary to validate
the incremental usefulness of these revisions.Critical Care    Vol 13 No 5 Pickering and Endre
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